Chintu Patel insider trades
Open-market stock purchases and sales by Chintu Patel, Co-CEO at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since May 7, 2018.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +242%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $385K |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $4.2M |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $228K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- AMRX Amneal Pharmaceuticals, Inc: 6 buys, last Mar 4, 2026